Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$1.80
+7.49%
Mkt Cap $93.40M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
Implied Upside
+206.4%
Consensus $5.50 vs current $1.80
NASDAQ·Healthcare·Biotechnology
$1.80
+7.49%
Mkt Cap $93.40M
Buy
4
Hold
0
Sell
0
Price Target (8 analysts)
$5.50
Range $5.00 – $6.00
+206.4%
Consensus $5.50 vs current $1.80